Biocryst Pharmaceuticals (BCRX) Gross Profit (2010 - 2026)
Biocryst Pharmaceuticals' (BCRX) quarterly Gross Profit came in at $151.0 million in Q1 2026, up 7.14% YoY from $141.0 million in Q1 2025, and up 1813.59% on a QoQ basis from -$8.8 million in Q4 2025.
Biocryst Pharmaceuticals (BCRX) Gross Profit (2010 - 2026) Analysis & Trends
Biocryst Pharmaceuticals (BCRX) has 16 years of Gross Profit data on file, last reported at $151.0 million in Q1 2026.
- Quarterly Gross Profit rose 7.14% year-over-year to $151.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $460.0 million (down 5.72% YoY) and the FY2025 annual result came in at $855.8 million, up 95.18% from the prior year.
- Gross Profit climbed to $151.0 million in Q1 2026, from -$8.8 million in the prior quarter.
- In the past five years, Gross Profit ranged from a high of $160.6 million in Q2 2025 to a low of -$8.8 million in Q4 2025.
- A 5-year average of $95.9 million and a median of $91.5 million in 2024 frame the typical range for Gross Profit.
- Annual changes were most pronounced in 2022 — Gross Profit soared 278.25% — and 2025, when it sank 107.03%.
- Tracing BCRX's Gross Profit over 5 years: stood at $77.2 million in 2022, then increased by 19.03% to $91.8 million in 2023, then jumped by 36.58% to $125.4 million in 2024, then plunged by 107.03% to -$8.8 million in 2025, then soared by 1813.59% to $151.0 million in 2026.
- The last three Gross Profit figures came in at $151.0 million (Q1 2026), -$8.8 million (Q4 2025), and $157.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - |
| 10 | Biocryst Pharmaceuticals | 2.45 Bn | 2.10 Bn | 214.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 214.41 Mn |
| Jun 30, 2026 | 214.41 Mn |
| Mar 31, 2026 | 151.04 Mn |
| Mar 31, 2026 | 151.04 Mn |
| Dec 31, 2025 | -8.81 Mn |
| Dec 31, 2025 | -8.81 Mn |
| Sep 30, 2025 | 157.21 Mn |
| Sep 30, 2025 | 157.21 Mn |
| Jun 30, 2025 | 160.56 Mn |
| Jun 30, 2025 | 160.56 Mn |
| Mar 31, 2025 | 140.97 Mn |
| Mar 31, 2025 | 140.97 Mn |
| Dec 31, 2024 | 125.44 Mn |
| Dec 31, 2024 | 125.44 Mn |
| Sep 30, 2024 | 113.87 Mn |
| Sep 30, 2024 | 113.87 Mn |
| Jun 30, 2024 | 107.63 Mn |
| Jun 30, 2024 | 107.63 Mn |
| Mar 31, 2024 | 91.50 Mn |
| Mar 31, 2024 | 91.50 Mn |